179 related articles for article (PubMed ID: 24076587)
1. Mapping the p53 transcriptome universe using p53 natural polymorphs.
Wang B; Niu D; Lam TH; Xiao Z; Ren EC
Cell Death Differ; 2014 Apr; 21(4):521-32. PubMed ID: 24076587
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
3. p53-directed translational control can shape and expand the universe of p53 target genes.
Zaccara S; Tebaldi T; Pederiva C; Ciribilli Y; Bisio A; Inga A
Cell Death Differ; 2014 Oct; 21(10):1522-34. PubMed ID: 24926617
[TBL] [Abstract][Full Text] [Related]
4. ChIP (chromatin immunoprecipitation) analysis demonstrates co-ordinated binding of two transcription factors to the promoter of the p53 tumour-suppressor gene.
Polson A; Takahashi P; Reisman D
Cell Biol Int; 2010 Sep; 34(9):883-91. PubMed ID: 20446924
[TBL] [Abstract][Full Text] [Related]
5. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney.
Li Y; Liu J; McLaughlin N; Bachvarov D; Saifudeen Z; El-Dahr SS
Physiol Genomics; 2013 Oct; 45(20):948-64. PubMed ID: 24003036
[TBL] [Abstract][Full Text] [Related]
7. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
[TBL] [Abstract][Full Text] [Related]
8. Human single-nucleotide polymorphisms alter p53 sequence-specific binding at gene regulatory elements.
Bandele OJ; Wang X; Campbell MR; Pittman GS; Bell DA
Nucleic Acids Res; 2011 Jan; 39(1):178-89. PubMed ID: 20817676
[TBL] [Abstract][Full Text] [Related]
9. Stathmin/oncoprotein 18, a microtubule regulatory protein, is required for survival of both normal and cancer cell lines lacking the tumor suppressor, p53.
Carney BK; Cassimeris L
Cancer Biol Ther; 2010 May; 9(9):699-709. PubMed ID: 20200495
[TBL] [Abstract][Full Text] [Related]
10. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
[TBL] [Abstract][Full Text] [Related]
12. Repression of new p53 targets revealed by ChIP on chip experiments.
Ceribelli M; Alcalay M; Viganò MA; Mantovani R
Cell Cycle; 2006 May; 5(10):1102-10. PubMed ID: 16721047
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the legumain gene by p53 in HCT116 cells.
Yamane T; Murao S; Kato-Ose I; Kashima L; Yuguchi M; Kozuka M; Takeuchi K; Ogita H; Ohkubo I; Ariga H
Biochem Biophys Res Commun; 2013 Sep; 438(4):613-8. PubMed ID: 23942113
[TBL] [Abstract][Full Text] [Related]
14. The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration.
Hall AE; Lu WT; Godfrey JD; Antonov AV; Paicu C; Moxon S; Dalmay T; Wilczynska A; Muller PA; Bushell M
Cell Death Dis; 2016 Apr; 7(4):e2184. PubMed ID: 27054339
[TBL] [Abstract][Full Text] [Related]
15. p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells.
Kim NH; Cha YH; Kang SE; Lee Y; Lee I; Cha SY; Ryu JK; Na JM; Park C; Yoon HG; Park GJ; Yook JI; Kim HS
Cell Cycle; 2013 May; 12(10):1578-87. PubMed ID: 23624843
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress.
Coronel L; Riege K; Schwab K; Förste S; Häckes D; Semerau L; Bernhart SH; Siebert R; Hoffmann S; Fischer M
Nucleic Acids Res; 2021 Jul; 49(13):7437-7456. PubMed ID: 34197623
[TBL] [Abstract][Full Text] [Related]
17. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide identification of Wig-1 mRNA targets by RIP-Seq analysis.
Bersani C; Huss M; Giacomello S; Xu LD; Bianchi J; Eriksson S; Jerhammar F; Alexeyenko A; Vilborg A; Lundeberg J; Lui WO; Wiman KG
Oncotarget; 2016 Jan; 7(2):1895-911. PubMed ID: 26672765
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
20. TRIM8 modulates p53 activity to dictate cell cycle arrest.
Caratozzolo MF; Micale L; Turturo MG; Cornacchia S; Fusco C; Marzano F; Augello B; D'Erchia AM; Guerrini L; Pesole G; Sbisà E; Merla G; Tullo A
Cell Cycle; 2012 Feb; 11(3):511-23. PubMed ID: 22262183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
